• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

综合蛋白质组学和代谢组学分析确定了与肥胖相关的独特分子特征和代谢途径以及抗肥胖治疗的潜在靶点。

Integrated proteomic and metabolomic profiling identifies distinct molecular signatures and metabolic pathways associated with obesity and potential targets for anti-obesity therapies.

作者信息

Li Yi, Yang Huawu, Zhang Xinpeng, He Xingyu, Liuli Anke, Li Rui, Han Xingyu, Li Yongmei, Gao Pan

机构信息

Department of Radiology, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.

Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

出版信息

Front Endocrinol (Lausanne). 2025 Jul 31;16:1625501. doi: 10.3389/fendo.2025.1625501. eCollection 2025.

DOI:10.3389/fendo.2025.1625501
PMID:40822952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12350109/
Abstract

BACKGROUND

Adipose tissue remodeling induced by bariatric surgery plays a pivotal role in promoting weight loss and metabolic improvement. However, the underlying molecular mechanisms, particularly protein-metabolite regulatory networks, remain poorly understood. This integrative proteomic and metabolomic study identifies key pathway alterations and molecular signatures associated with metabolic phenotypes, offering novel mechanistic insights into the therapeutic efficacy of bariatric surgery.

METHODS

Visceral adipose tissue samples were analyzed using label-free DIA quantitative proteomics and LC-MS/MS metabolomics. Proteomic and metabolomic data were processed with MaxQuant software and XCMS R package, respectively.

RESULTS

Proteomic and metabolomic analyses were performed on visceral adipose tissue from 10 obese patients undergoing sleeve gastrectomy and 10 controls. Proteomic profiling quantified identified 135 differentially expressed proteins (57 upregulated, 78 downregulated), with PHACTR2 and PLIN2 upregulated in obesity and ADAR down-regulated in obesity. Enrichment analyses indicated disruptions in lipid droplet formation, muscle processes, and protein autophosphorylation, with KRT1/MYH9 and NF1/ATR identified as hub proteins. Metabolomics revealed 191 differential metabolites (110 upregulated, 81 downregulated), with 4-Vinylcyclohexene positively correlated with BMI and asparagine-betaxanthin negatively correlated. KEGG analysis showed disturbances in purine/pyrimidine metabolism, AMPK signaling, and cortisol biosynthesis. Integrated protein-metabolite network analysis identified OSBPL10, CUL2, and PRTN3 as potential regulators of lipid metabolism and insulin resistance, offering insights into obesity-associated metabolic dysfunction.

CONCLUSIONS

This study integrated proteomic and metabolomic data from visceral adipose tissue obtained through sleeve gastrectomy, identifying obesity-related functional pathways and molecular signatures linked to metabolic phenotypes, highlighting the value of multi-omics in understanding adipose tissue remodeling and postoperative metabolic improvement.

摘要

背景

减肥手术诱导的脂肪组织重塑在促进体重减轻和代谢改善方面起着关键作用。然而,其潜在的分子机制,尤其是蛋白质-代谢物调控网络,仍知之甚少。这项蛋白质组学和代谢组学的综合研究确定了与代谢表型相关的关键通路改变和分子特征,为减肥手术的治疗效果提供了新的机制见解。

方法

使用无标记DIA定量蛋白质组学和LC-MS/MS代谢组学分析内脏脂肪组织样本。蛋白质组学和代谢组学数据分别用MaxQuant软件和XCMS R包进行处理。

结果

对10例接受袖状胃切除术的肥胖患者和10例对照者的内脏脂肪组织进行了蛋白质组学和代谢组学分析。蛋白质组分析定量鉴定出135种差异表达蛋白(57种上调,78种下调),其中PHACTR2和PLIN2在肥胖中上调,ADAR在肥胖中下调。富集分析表明脂滴形成、肌肉过程和蛋白质自磷酸化受到破坏,KRT1/MYH9和NF1/ATR被确定为枢纽蛋白。代谢组学揭示了191种差异代谢物(110种上调,81种下调),4-乙烯基环己烯与BMI呈正相关,天冬酰胺-甜菜黄素呈负相关。KEGG分析显示嘌呤/嘧啶代谢、AMPK信号通路和皮质醇生物合成受到干扰。综合蛋白质-代谢物网络分析确定OSBPL10、CUL2和PRTN3为脂质代谢和胰岛素抵抗的潜在调节因子,为肥胖相关代谢功能障碍提供了见解。

结论

本研究整合了通过袖状胃切除术获得的内脏脂肪组织的蛋白质组学和代谢组学数据,确定了与代谢表型相关的肥胖相关功能通路和分子特征,突出了多组学在理解脂肪组织重塑和术后代谢改善方面的价值。

相似文献

1
Integrated proteomic and metabolomic profiling identifies distinct molecular signatures and metabolic pathways associated with obesity and potential targets for anti-obesity therapies.综合蛋白质组学和代谢组学分析确定了与肥胖相关的独特分子特征和代谢途径以及抗肥胖治疗的潜在靶点。
Front Endocrinol (Lausanne). 2025 Jul 31;16:1625501. doi: 10.3389/fendo.2025.1625501. eCollection 2025.
2
Obesity duration is linked to bariatric surgery outcomes via adipose tissue response.肥胖持续时间通过脂肪组织反应与减肥手术结果相关联。
J Endocrinol. 2025 Aug 6;266(2). doi: 10.1530/JOE-25-0013. Print 2025 Aug 1.
3
Integrated multi-omics for potential biomarkers and molecular mechanism of persistent inflammatory refractory rheumatoid arthritis.用于持续性炎症难治性类风湿关节炎潜在生物标志物和分子机制的综合多组学研究
Front Immunol. 2025 Jul 25;16:1574783. doi: 10.3389/fimmu.2025.1574783. eCollection 2025.
4
Multi-Omics insights into the molecular mechanisms of trochlear dysplasia: A proteomic and metabolomic study in rats.多组学洞察滑车发育不良的分子机制:大鼠的蛋白质组学和代谢组学研究
PLoS One. 2025 Aug 11;20(8):e0325562. doi: 10.1371/journal.pone.0325562. eCollection 2025.
5
Integrated plasma metabolomics and lipidomics profiling highlight distinctive signatures with hashimoto's thyroiditis.综合血浆代谢组学和脂质组学分析突出了桥本甲状腺炎的独特特征。
Sci Rep. 2025 Jul 1;15(1):21081. doi: 10.1038/s41598-025-07905-7.
6
Proteomic and metabolomic analysis of serum in women infected with COVID-19 during late pregnancy.妊娠晚期感染新型冠状病毒肺炎的女性血清蛋白质组学和代谢组学分析
Front Immunol. 2025 Jun 11;16:1589239. doi: 10.3389/fimmu.2025.1589239. eCollection 2025.
7
The metabolome of fecal extracellular vesicles in patients with malignant solid tumors.恶性实体瘤患者粪便细胞外囊泡的代谢组
Sci Rep. 2025 Aug 11;15(1):29402. doi: 10.1038/s41598-025-14250-2.
8
Metabolomics and proteomics analyses of zebrafish exposed to mesaconitine from Aconitum plants reveal marked reductions in lipid, glycolytic pathways.对暴露于乌头属植物中甲基乌头碱的斑马鱼进行代谢组学和蛋白质组学分析,结果显示脂质和糖酵解途径显著减少。
Ecotoxicol Environ Saf. 2025 Sep 1;302:118769. doi: 10.1016/j.ecoenv.2025.118769. Epub 2025 Jul 30.
9
Study on the modulation of kidney and liver function of rats with diabetic nephropathy by Huidouba through metabolomics.回豆巴通过代谢组学对糖尿病肾病大鼠肝肾功 能的调节作用研究
J Ethnopharmacol. 2025 Jun 11;351:120136. doi: 10.1016/j.jep.2025.120136.
10
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.减肥手术治疗肥胖症的临床疗效和成本效益:一项系统评价与经济评估
Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410.

本文引用的文献

1
The Change of Skeletal Muscle Caused by Inflammation in Obesity as the Key Path to Fibrosis: Thoughts on Mechanisms and Intervention Strategies.肥胖炎症引起的骨骼肌变化作为纤维化的关键途径:机制与干预策略思考
Biomolecules. 2024 Dec 27;15(1):20. doi: 10.3390/biom15010020.
2
Metabolomic Hallmarks of Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease.肥胖及代谢功能障碍相关脂肪性肝病的代谢组学特征
Int J Mol Sci. 2024 Nov 28;25(23):12809. doi: 10.3390/ijms252312809.
3
Directly targeting PRDM16 in thermogenic adipose tissue to treat obesity and its related metabolic diseases.
直接靶向生热脂肪组织中的 PRDM16 以治疗肥胖及其相关代谢疾病。
Front Endocrinol (Lausanne). 2024 Sep 16;15:1458848. doi: 10.3389/fendo.2024.1458848. eCollection 2024.
4
Obesity and cardiovascular disease: an ESC clinical consensus statement.肥胖与心血管病:ESC 临床共识声明
Eur Heart J. 2024 Oct 7;45(38):4063-4098. doi: 10.1093/eurheartj/ehae508.
5
Deciphering the complex interplay of obesity, epithelial barrier dysfunction, and tight junction remodeling: Unraveling potential therapeutic avenues.解析肥胖、上皮屏障功能障碍和紧密连接重塑的复杂相互作用:揭示潜在的治疗途径。
Obes Rev. 2024 Aug;25(8):e13766. doi: 10.1111/obr.13766. Epub 2024 May 14.
6
A Systematic Review of Proteomics in Obesity: Unpacking the Molecular Puzzle.肥胖症蛋白质组学的系统评价:揭开分子谜题。
Curr Obes Rep. 2024 Sep;13(3):403-438. doi: 10.1007/s13679-024-00561-4. Epub 2024 May 4.
7
Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults.全球范围内 1990 年至 2022 年体重不足和肥胖趋势:对 3663 项具有 2.22 亿儿童、青少年和成年人代表性的人群研究进行的汇总分析。
Lancet. 2024 Mar 16;403(10431):1027-1050. doi: 10.1016/S0140-6736(23)02750-2. Epub 2024 Feb 29.
8
Long-term effect of sleeve gastrectomy vs Roux-en-Y gastric bypass in people living with severe obesity: a phase III multicentre randomised controlled trial (SleeveBypass).袖状胃切除术与Roux-en-Y胃旁路术对重度肥胖患者的长期影响:一项III期多中心随机对照试验(袖状胃切除术与胃旁路术对比试验)
Lancet Reg Health Eur. 2024 Jan 22;38:100836. doi: 10.1016/j.lanepe.2024.100836. eCollection 2024 Mar.
9
Lipid remodeling of adipose tissue in metabolic health and disease.脂肪组织在代谢健康和疾病中的脂质重塑。
Exp Mol Med. 2023 Sep;55(9):1955-1973. doi: 10.1038/s12276-023-01071-4. Epub 2023 Sep 1.
10
Patient-reported outcomes, weight loss, and remission of type 2 diabetes 3 years after gastric bypass and sleeve gastrectomy (Oseberg); a single-centre, randomised controlled trial.胃旁路术和袖状胃切除术 3 年后患者报告结局、体重减轻和 2 型糖尿病缓解(Oseberg):单中心随机对照试验。
Lancet Diabetes Endocrinol. 2023 Aug;11(8):555-566. doi: 10.1016/S2213-8587(23)00127-4. Epub 2023 Jul 3.